The Medibank Private Ltd (ASX: MPL) share price has travelled modestly over the course of the new year. This comes as the private health insurance giant continues to navigate its way through COVID-19.
At Friday’s market close, Medibank shares touched a 52-week high of $3.63 before slightly retracing to $3.60, up 5.88%.
In contrast, the S&P/ASX 200 Index (ASX: XJO) ended the day 1.29% higher at 7,453.3 points.
Investors may be wondering what’s ahead for Medibank in 2022. Below, we look at some of the key dates to watch out for.
What’s ahead for Medibank in 2022?
Australia’s leading health insurance provider recently released its calendar for the 2022 financial year.
The first date of note is just around the corner on 25 February, when Medibank plans to deliver its half-year results for FY22. Along with its six-month performance report, the company will also announce the 2022 interim dividend.
The ex-dividend date for the interim dividend is scheduled for the following week, on 4 March. This is when investors must have purchased Medibank shares to be eligible for the upcoming interim dividend payment.
The payment date for the interim dividend is set for 24 March, when investors will collect a portion of the company’s profits.
Medibank handed shareholders a fully franked interim dividend of 5.8 cents per share for the first half of FY21.
The above process will repeat itself with Medibank releasing its full-year results and full-year dividend sometime in August. Although these dates are yet to be released by the company.
Medibank share price snapshot
Based on valuation grounds, Medibank presides a market capitalisation of roughly $9.91 billion, with approximately 2.75 billion shares on issue.
The company currently has a trailing dividend yield of 3.53% and a price-to-earnings (P/E) ratio of 22.50.
The post Own Medibank (ASX:MPL) shares? Here are some key dates to watch in 2022 appeared first on The Motley Fool Australia.
Should you invest $1,000 in Medibank Private right now?
Before you consider Medibank Private, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Medibank Private wasn’t one of them.
The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of August 16th 2021
More reading
- How did the Medibank (ASX:MPL) share price perform in 2021?
- Here are the top 10 ASX shares today
- Why Afterpay, BrainChip, Medibank, and WiseTech shares are racing higher
- ASX 200 (ASX:XJO): Woolworths withdraws API proposal, tech shares rebound
- What’s happening to the Medibank (ASX:MPL) share price today?
Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/3GnBSjG
Leave a Reply